04-Nov-2026 14:36:26
ALEMBIC PHARMACEUTICALS Q2 FY27: REVENUE UP 36% YOY, PAT SURGES 81%, EBITDA JUMPS 78%; US BUSINESS GROWS 77% DRIVEN BY STRONG VOLUMES & NEW LAUNCHES
• Revenue: Increased 36% YoY to ₹2,603 Cr. • EBITDA: Jumped 78% YoY to ₹578 Cr, with margin at 22%. • Net Profit: Surged 81% YoY to ₹335 Cr. • US Business: Rev…